Godrej Consumer Products Limited

NSEI:GODREJCP Stock Report

Market Cap: ₹1.1t

Godrej Consumer Products Valuation

Is GODREJCP undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of GODREJCP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: GODREJCP (₹1069.6) is trading above our estimate of fair value (₹398.41)

Significantly Below Fair Value: GODREJCP is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for GODREJCP?

Key metric: As GODREJCP is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for GODREJCP. This is calculated by dividing GODREJCP's market cap by their current revenue.
What is GODREJCP's PS Ratio?
PS Ratio7.8x
Sales₹140.43b
Market Cap₹1.09t

Price to Sales Ratio vs Peers

How does GODREJCP's PS Ratio compare to its peers?

The above table shows the PS ratio for GODREJCP vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average10.6x
DABUR Dabur India
7.2x8.7%₹890.7b
500830 Colgate-Palmolive (India)
12.5x8.5%₹748.2b
500459 Procter & Gamble Hygiene and Health Care
11.7x10.3%₹490.7b
507815 Gillette India
11.2xn/a₹306.6b
GODREJCP Godrej Consumer Products
7.8x10.0%₹1.1t

Price-To-Sales vs Peers: GODREJCP is good value based on its Price-To-Sales Ratio (7.8x) compared to the peer average (10.6x).

Price to Sales Ratio vs Industry

How does GODREJCP's PS Ratio compare vs other companies in the IN Personal Products Industry?

5 CompaniesPrice / SalesEstimated GrowthMarket Cap
530689 Lykis
0.2xn/aUS$10.29m
542248 Deccan Health Care
1xn/aUS$7.34m
524703 Sandu Pharmaceuticals
0.8xn/aUS$6.41m
WALPAR Walpar Nutritions
0.7xn/aUS$5.18m
GODREJCP 7.8xIndustry Avg. 6.4xNo. of Companies5PS048121620+
5 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: GODREJCP is expensive based on its Price-To-Sales Ratio (7.8x) compared to the Indian Personal Products industry average (6.4x).

Price to Sales Ratio vs Fair Ratio

What is GODREJCP's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

GODREJCP PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio7.8x
Fair PS Ratio9.6x

Price-To-Sales vs Fair Ratio: GODREJCP is good value based on its Price-To-Sales Ratio (7.8x) compared to the estimated Fair Price-To-Sales Ratio (9.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst GODREJCP forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹1,069.60
₹1,408.94
+31.7%
9.5%₹1,680.00₹1,000.00n/a36
Dec ’25₹1,244.65
₹1,455.58
+16.9%
8.6%₹1,680.00₹1,035.00n/a36
Nov ’25₹1,275.10
₹1,457.17
+14.3%
8.8%₹1,680.00₹1,035.00n/a35
Oct ’25₹1,388.25
₹1,530.69
+10.3%
9.1%₹1,715.00₹1,020.00n/a35
Sep ’25₹1,481.20
₹1,535.94
+3.7%
9.2%₹1,715.00₹1,020.00n/a35
Aug ’25₹1,470.25
₹1,435.91
-2.3%
8.3%₹1,652.00₹1,079.00n/a35
Jul ’25₹1,398.05
₹1,425.46
+2.0%
7.9%₹1,652.00₹1,079.00n/a35
Jun ’25₹1,270.35
₹1,400.89
+10.3%
8.2%₹1,580.00₹1,079.00n/a36
May ’25₹1,219.50
₹1,314.00
+7.7%
9.5%₹1,520.00₹1,025.00n/a35
Apr ’25₹1,228.35
₹1,301.12
+5.9%
9.9%₹1,520.00₹996.00n/a34
Mar ’25₹1,267.45
₹1,287.41
+1.6%
9.5%₹1,520.00₹996.00n/a34
Feb ’25₹1,254.55
₹1,260.85
+0.5%
8.8%₹1,520.00₹996.00n/a34
Jan ’25₹1,144.80
₹1,148.82
+0.4%
7.2%₹1,350.00₹930.00n/a34
Dec ’24₹1,025.40
₹1,130.59
+10.3%
6.5%₹1,250.00₹930.00₹1,244.6534
Nov ’24₹974.65
₹1,131.88
+16.1%
6.8%₹1,315.00₹930.00₹1,275.1033
Oct ’24₹991.60
₹1,143.94
+15.4%
6.7%₹1,315.00₹970.00₹1,388.2532
Sep ’24₹1,005.35
₹1,140.33
+13.4%
6.9%₹1,315.00₹970.00₹1,481.2033
Aug ’24₹1,020.45
₹1,121.76
+9.9%
7.3%₹1,315.00₹975.00₹1,470.2533
Jul ’24₹1,081.00
₹1,098.06
+1.6%
7.1%₹1,225.00₹908.00₹1,398.0532
Jun ’24₹1,054.20
₹1,086.66
+3.1%
7.0%₹1,200.00₹908.00₹1,270.3532
May ’24₹907.50
₹1,041.44
+14.8%
7.6%₹1,200.00₹888.00₹1,219.5032
Apr ’24₹968.15
₹1,037.32
+7.1%
7.5%₹1,200.00₹880.00₹1,228.3531
Mar ’24₹912.05
₹1,022.86
+12.1%
7.5%₹1,152.00₹860.00₹1,267.4535
Feb ’24₹929.70
₹1,019.54
+9.7%
7.6%₹1,175.00₹860.00₹1,254.5535
Jan ’24₹874.05
₹961.23
+10.0%
9.0%₹1,175.00₹662.00₹1,144.8035
Dec ’23₹877.25
₹956.80
+9.1%
9.0%₹1,175.00₹662.00₹1,025.4035

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 21:44
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Godrej Consumer Products Limited is covered by 70 analysts. 35 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nihal JhamAmbit Capital
Ajay ThakurAnand Rathi Shares and Stock Brokers Limited
null nullAnand Rathi Shares and Stock Brokers Limited